A detailed history of Central Pacific Bank Trust Division transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 18,335 shares of BMY stock, worth $1.05 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
18,335
Previous 18,639 1.63%
Holding current value
$1.05 Million
Previous $774 Million 22.55%
% of portfolio
0.12%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$39.66 - $51.75 $12,056 - $15,732
-304 Reduced 1.63%
18,335 $949 Million
Q2 2024

Jul 30, 2024

BUY
$40.25 - $52.99 $43,228 - $56,911
1,074 Added 6.11%
18,639 $774 Million
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $842,768 - $955,536
17,565 New
17,565 $931 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.